Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VUG vs GSK✓SelectedUSD · GSKVUG vs GSK performance historyLatest closeAs of-2.51%11/16
Stock and ETF performance explorer

VUG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+56.9%
GSK return
+46.9%
Excess return
+10.0%
Maximum drawdown
-35.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.5%-0.1%-2.4%-2.5%
7D-2.8%-1.3%-1.4%-2.6%
30D-6.6%+2.7%-9.3%-6.9%
3M-8.0%+2.7%-10.7%-8.4%
6M-5.9%+3.3%-9.2%-6.5%
YTD+1.3%+6.5%-5.1%-0.1%
1Y+2.3%+10.7%-8.3%+0.3%
3Y+69.3%+64.4%+4.9%+50.6%
5Y+56.9%+46.7%+10.3%+33.7%
All+56.9%+46.9%+10.0%+33.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling